Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

By A Mystery Man Writer

Last updated 16 Jun 2024

Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system.

Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer: Molecular Therapy - Oncolytics

Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme - Ahmed - 2023 - MedComm – Oncology - Wiley Online Library

Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Frontiers An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme - Ahmed - 2023 - MedComm – Oncology - Wiley Online Library

Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy - ScienceDirect

Oncolytic Viruses and the Immune System: The Dynamic Duo: Molecular Therapy Methods & Clinical Development

Oncolytic virotherapy: Challenges and solutions - ScienceDirect

Exploring the role of oncolytic viruses in hepatobiliary cancers

A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon: Molecular Therapy - Oncolytics

Oncolytic viruses in lung cancer treatment: a review article

Recommended for you